Invalid date chosen. Displaying data for the latest date instead.

Technical Analysis for GLMD - Galmed Pharmaceuticals Ltd.

Grade Last Price % Change Price Change
D 0.40 -1.83% -0.01
GLMD closed down 1.83 percent on Monday, May 20, 2024, on 13 percent of normal volume.
Earnings due: May 30
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Flat

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Gapped Up Strength 0.00%
20 DMA Support Bullish -1.83%
Pocket Pivot Bullish Swing Setup -1.83%
Crossed Above 20 DMA Bullish -0.35%
Pocket Pivot Bullish Swing Setup -0.35%
NR7 Range Contraction -0.35%
Fell Below 20 DMA Bearish 3.57%
MACD Bearish Signal Line Cross Bearish 3.57%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 3.57%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High about 7 hours ago
Up 3% about 7 hours ago
Up 2% about 7 hours ago
Up 1% about 7 hours ago
20 DMA Support 3 days ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

GalMed Medical Research Ltd. researches and develops proprietary drugs for the treatment of lipid metabolism related diseases. The company has developed a series of proprietary fatty acid bile-acid conjugates (FABACs) which selectively inhibit the enzyme Stearoyl-CoA Desaturase (SCD1), a key regulator in lipid metabolism. It's flagship clinical compound Aramchol (arachidyl amido cholanoic acid), has the potential to modify several of the key disorders related to lipid metabolism, including fatty liver, gallstones, diabetes, hyperlipidemia, cancer, and alzheimer's disease. The company is based in Tel Aviv, Israel. GalMed Medical Research Ltd. operates as a subsidiary of Galmed International Ltd.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Acid Diabetes Alzheimer's Disease Lipid Medical Research Metabolism Hepatology Fatty Acids Fatty Liver Hyperlipidemia

Is GLMD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.49
52 Week Low 0.2601
Average Volume 212,415
200-Day Moving Average 0.46
50-Day Moving Average 0.37
20-Day Moving Average 0.39
10-Day Moving Average 0.40
Average True Range 0.03
RSI (14) 51.92
ADX 16.47
+DI 23.33
-DI 14.27
Chandelier Exit (Long, 3 ATRs) 0.33
Chandelier Exit (Short, 3 ATRs) 0.44
Upper Bollinger Bands 0.42
Lower Bollinger Band 0.36
Percent B (%b) 0.59
BandWidth 15.91
MACD Line 0.01
MACD Signal Line 0.01
MACD Histogram -0.0008
Fundamentals Value
Market Cap 1.59 Million
Num Shares 4.01 Million
EPS -3.02
Price-to-Earnings (P/E) Ratio -0.13
Price-to-Sales 0.00
Price-to-Book 0.09
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.44
Resistance 3 (R3) 0.44 0.43 0.43
Resistance 2 (R2) 0.43 0.42 0.43 0.43
Resistance 1 (R1) 0.41 0.41 0.41 0.41 0.43
Pivot Point 0.40 0.40 0.40 0.40 0.40
Support 1 (S1) 0.39 0.39 0.38 0.38 0.37
Support 2 (S2) 0.38 0.39 0.37 0.37
Support 3 (S3) 0.36 0.38 0.36
Support 4 (S4) 0.36